Business

Leonardo DRS Announces Financial Results for First Quarter 2025

Revenue: $799 million, up 16% year-over-year Net Earnings: $50 million, up 72% year-over-year Adjusted EBITDA: $82 million, up 17% year-over-year Diluted

articleLeonardo Drs, Inc.May 1, 20254/company/leonardo-drs-inc-common-stock/news/leonardo-drs-announces-financial-results-first-quarter-2025-2025-05-01
Leonardo DRS Announces Financial Results for First Quarter 2025

About this update from Leonardo Drs, Inc.

[{"type":"text","content":"\n\nRevenue: $799 million, up 16% year-over-year\n\n\nNet Earnings: $50 million, up 72% year-over-year\n\n\nAdjusted EBITDA: $82 million, up 17% year-over-year\n\n\nDiluted EPS: $0.19, up 73% year-over-year\n\n\nAdjusted Diluted EPS: $0.20, up 43% year-over-year\n\n\nBookings: $1 billion (book-to-bill ratio of 1.2x)\n\n\nBacklog: $8.6 billion, up 10% year-over-year\n\n\nConfirms strong 2025 guidance across all metrics\n\n\n ARLINGTON, Va.--(BUSINESS WIRE)--\nLeonardo DRS, Inc. (Nasdaq: DRS), a leading provider of advanced defense technologies, today reported financial results for the first quarter 2025, which ended March 31, 2025.\n\nCEO Commentary\n\n“Our first quarter 2025 financial results exceeded our expectations and reflect a solid start to the year. Our differentiated portfolio continues to exhibit strong customer demand, which is also translating into healthy organic revenue growth. Additionally, in the quarter we drove improved profitability and reduced free cash flow usage compared to last year. Amidst a more dynamic operating environment, we remain focused on maintaining sharp execution throughout 2025 to meet our commitments to shareholders and customers,” said Bill Lynn, Chairman and CEO of Leonardo DRS.\n\nSummary Financial Results\n\n\n\n(In millions, except per share amounts)\n\n\n\nThree Months Ended\n\n\n\n \n\n\n\n \n\n\n\n\n\nMarch 31,\n\n\n\n \n\n\n\n \n\n\n\n\n\n \n\n\n\n \n\n\n\n2025\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n2024\n\n\n\n \n\n\n\n \n\n\n\nChange\n\n\n\n\n\nRevenues\n\n\n\n$\n\n\n\n799\n\n\n\n \n\n\n\n \n\n\n\n$\n\n\n\n688\n\n\n\n \n\n\n\n \n\n\n\n16\n\n\n\n%\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nNet Earnings\n\n\n\n$\n\n\n\n50\n\n\n\n \n\n\n\n \n\n\n\n$\n\n\n\n29\n\n\n\n \n\n\n\n \n\n\n\n72\n\n\n\n%\n\n\n\n\n\nDiluted WASO\n\n\n\n \n\n\n\n268.775\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n266.443\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nDiluted Earnings Per Share (EPS)\n\n\n\n$\n\n\n\n0.19\n\n\n\n \n\n\n\n \n\n\n\n$\n\n\n\n0.11\n\n\n\n \n\n\n\n \n\n\n\n73\n\n\n\n%\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nNon-GAAP Financial Measures (1)\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nAdjusted EBITDA\n\n\n\n$\n\n\n\n82\n\n\n\n \n\n\n\n \n\n\n\n$\n\n\n\n70\n\n\n\n \n\n\n\n \n\n\n\n17\n\n\n\n%\n\n\n\n\n\nAdjusted EBITDA Margin\n\n\n\n \n\n\n\n10.3\n\n\n\n%\n\n\n\n \...

More updates from Leonardo Drs, Inc.